See more : MTR Corporation Limited (MTCPY) Income Statement Analysis – Financial Results
Complete financial analysis of OK Science and Technology Co., Ltd. (001223.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of OK Science and Technology Co., Ltd., a leading company in the Industrial – Machinery industry within the Industrials sector.
- Ter Beke NV (TERB.BR) Income Statement Analysis – Financial Results
- Vickers Vantage Corp. I (VCKAU) Income Statement Analysis – Financial Results
- Duke Realty Corporation (0ID0.L) Income Statement Analysis – Financial Results
- St. Galler Kantonalbank AG (0QQZ.L) Income Statement Analysis – Financial Results
- TotalEnergies SE (TTFNF) Income Statement Analysis – Financial Results
OK Science and Technology Co., Ltd. (001223.SZ)
About OK Science and Technology Co., Ltd.
OK Science and Technology Co., Ltd. designs and manufactures tissue paper machines, and converting and packing machines for facial tissues, napkin tissues, toilet paper kitchen towels, and pocket tissues. It also provides tissue making machines, disposable surgical mask making machines, and KN95 mask making machines. The company was founded in 2011 and is based in Jiujiang, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 332.30M | 516.90M | 558.46M | 528.81M | 226.21M | 185.65M |
Cost of Revenue | 227.30M | 275.03M | 293.08M | 175.56M | 116.21M | 94.99M |
Gross Profit | 105.00M | 241.87M | 265.38M | 353.26M | 110.00M | 90.66M |
Gross Profit Ratio | 31.60% | 46.79% | 47.52% | 66.80% | 48.63% | 48.83% |
Research & Development | 23.23M | 22.20M | 25.55M | 22.73M | 13.69M | 11.17M |
General & Administrative | 8.70M | 9.27M | 6.77M | 6.88M | 4.60M | 11.97M |
Selling & Marketing | 11.39M | 18.28M | 13.80M | 14.25M | 14.96M | 12.81M |
SG&A | 20.08M | 27.56M | 20.57M | 21.13M | 19.56M | 24.77M |
Other Expenses | -56.60M | 1.72M | -103.45K | -2.37M | -160.73K | 13.68K |
Operating Expenses | -13.29M | 18.33M | -885.19K | 45.87M | 33.23M | 36.84M |
Cost & Expenses | 214.21M | 293.36M | 292.19M | 221.43M | 149.45M | 131.83M |
Interest Income | 24.81M | 2.64M | 894.01K | 2.23M | 86.59K | 55.38K |
Interest Expense | 205.08K | 924.32K | 1.67M | 2.48M | 1.96M | 1.82M |
Depreciation & Amortization | 23.31M | 20.59M | 11.50M | 7.96M | 6.13M | 5.60M |
EBITDA | 151.51M | 235.81M | 275.84M | 298.15M | 75.85M | 55.93M |
EBITDA Ratio | 45.59% | 48.52% | 49.56% | 59.42% | 36.31% | 31.91% |
Operating Income | 118.10M | 212.78M | 262.97M | 290.14M | 67.92M | 48.50M |
Operating Income Ratio | 35.54% | 41.16% | 47.09% | 54.87% | 30.02% | 26.12% |
Total Other Income/Expenses | 9.90M | 1.72M | -103.45K | -2.37M | -160.74K | 13.68K |
Income Before Tax | 127.99M | 214.50M | 262.87M | 287.76M | 67.76M | 48.51M |
Income Before Tax Ratio | 38.52% | 41.50% | 47.07% | 54.42% | 29.95% | 26.13% |
Income Tax Expense | 14.06M | 31.28M | 34.25M | 41.07M | 8.76M | 6.19M |
Net Income | 113.93M | 183.22M | 228.63M | 246.70M | 59.00M | 42.32M |
Net Income Ratio | 34.29% | 35.45% | 40.94% | 46.65% | 26.08% | 22.80% |
EPS | 1.71 | 2.75 | 3.43 | 3.70 | 0.88 | 0.00 |
EPS Diluted | 1.71 | 2.75 | 3.43 | 3.70 | 0.88 | 0.00 |
Weighted Avg Shares Out | 66.68M | 66.68M | 66.68M | 66.68M | 66.68M | 0.00 |
Weighted Avg Shares Out (Dil) | 66.68M | 66.68M | 66.68M | 66.68M | 66.68M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports